A review of use of antibiotics in dentistry and recommendations for rational antibiotic usage by dentists. by Ramasamy, Akilesh
THE INTERNATIONAL ARABIC JOURNAL 
OF ANTIMICROBIAL AGENTS
© Under License of Creative Commons Attribution 3.0 License 1
2014
Vol. 4 No. 2:1
doi: 10.3823/748
iMedPub Journals
http://journals.imedpub.com
This article is available from: www.iajaa.org
A review of use of antibiotics in 
dentistry and recommendations 
for rational antibiotic usage by 
dentists*
Department of Oral and Maxillofacial 
Surgery Government Dental College & 
Hospital, Aurangabad, Maharashtra, India
Corresponding author:
akident@gmail.com
Dr. Akilesh Ramasamy
Abstract
Dentists commonly prescribe antibiotics for controlling and treating 
dental infections. But there is a widespread abuse of antibiotics in 
medical and dental field. The inappropriate use of antibiotics results 
in increased treatment costs, increased risk of adverse events related 
to the antibiotic used and most importantly development and propa-
gation of antimicrobial resistance. The definitive indications for use of 
antibiotics in dentistry are limited and specific. This review discusses 
the various principles and rationale behind antibiotic therapy in differ-
ent fields of dentistry with stress on rational antibiotic use in dentistry
Introduction
Dentistry is a comprehensive speciality devoted to resolving dental 
infections or restoring and rehabilitating tooth structure lost to such 
bacterial processes. The use of antibiotics is an integral part of den-
tistry and prescribing antibiotics is a privilege that must not be abused. 
Irrational use of antibiotics will lead to an increased burden on the 
patient and the society by increasing treatment costs, adverse events 
and also the risk of development of resistant bacterial species. Anti-
biotic abuse has already been considered as a pandemic community 
issue by World Health Organization (WHO) [1], whilst the abuse of 
antibiotics by dentists is worldwide as shown by many reports [2–5].
The oral cavity is a complex biological ecosystem with very large num-
ber of organisms living in a biofilm [6]. The interaction of the organisms 
are complex and the change from health to disease state is associ-
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ated with a change in the balance of the ecosystem 
usually from the resident facultative anaerobes to 
obligate anaerobes for most pulpal and periodontal 
diseases [7]. Even though only a few of the micro-
organisms cause odontogenic infections, in disease 
state, many other non pathogenic bacterial species 
contribute by maintaining an ecosystem favourable 
for survival and growth of the pathogenic species. 
The onset of disease is due to a shift in microbial 
flora. Understanding this ecological principle is im-
portant while treating oral and dental infections. 
Micro-organisms in a biofilm are consistently more 
resistant to usual dosage of antibiotics by 1000-
1500 fold [8].
Management of odontogenic infections involves 
three phases; diagnosis, infection control and re-
habilitation/restoration. Antibiotics are useful in the 
infection control phase. Based on the data collected 
and interpreted in the diagnostic phase, infection 
control phase involves removal of the infectious foci 
and resolving the infection. This will include use 
of antibiotics/antiseptic agents as well as surgical 
methods to resolve the infection. Until resolution of 
the infection, the response to the treatment should 
be assessed often.
Most dental pain is the result of infection induced 
inflammatory process in a closed compartment as 
in the pulp and the apical periodontal region or in 
sensitive and highly innervated soft tissue like the 
periosteum space, gingiva and periodontium. The 
general principle of management of all infectious 
processes is the removal of the foci of infection. 
Control of dental infections is by mechanical re-
moval of the foci of infection. It can be achieved 
by removal of the infected pulp, scaling and root 
planning and drainage of the pus by incision when 
the soft tissue spaces are involved. Usually a com-
bination of one or more of these techniques are 
utilised for maximum benefit. This, when supported 
by appropriate use of anti-inflammatory agents can 
result in prompt relief of pain as well as the infec-
tion. Antibiotics do not contribute to pain relief as 
they have no action on the inflammatory process 
that causes the pain [9–11]. With appropriate mea-
sures to remove the foci of infection, antibiotics are 
not necessary in most cases. An old surgical credo 
is “pus cannot be cured by penicillin”.
Principles of antibiotic usage 
 
In recent times, antimicrobial stewardship has been 
given lots of importance at the patient level and at 
the community level. Antimicrobial stewardship is 
defined as “the optimal selection, dosage, and du-
ration of antimicrobial treatment that results in the 
best clinical outcome for the treatment or preven-
tion of infection, with minimal toxicity to the patient 
and minimal impact on subsequent resistance.” Jo-
seph and Rodvold [12] summarised the 4 D's of an-
timicrobial therapy which is given in Table 1. An 
important consideration in starting antimicrobial 
therapy is to assess if the infection is localized and 
if the patient has an adequate immune response to 
control the bacteria if supported surgically. These 
considerations are summarised in Table 2.
In the presence of purulence, signs of inflamma-
tion, abscess or draining sinus tracts, the lesion/
infection responds to local debridement measures 
in a healthy patient [12,13]. In an otherwise healthy 
patient, infections that have not crossed the dento-
alveolar regions are amenable to treatment without 
Table 1. 4 D’s of antimicrobial therapy [12].
right Drug
right Dose
De-escalation to pathogen-directed therapy,
right Duration of therapy
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antibiotics. The infections that are about to breach 
the dentoalveolar regions and threaten to extend 
into deeper hard tissues or into the soft tissue fas-
cial spaces in the head and neck region will need 
use of appropriate antibiotics along with surgical 
therapy [14–16].
Antibiotics appropriate  
for dental use 
 
Different antibiotic prescribing trends are in practice 
among dentists [4,5,17]. Understanding the phar-
macokinetics and pharmacodynamics is important 
for appropriate use of the antibiotics. In spite of 
a large of number of newer antibiotics being in-
troduced in the market, there are a very few an-
tibiotics that are useful in dental infections. Most 
infections of dental origin still respond to penicillin 
group of antibiotics [18] and routine use of newer 
antibiotics only adds to the cost and risk of anti-
biotic resistance to these agents. Aminopenicillins 
are not active against anaerobes but odontogenic 
infections that show anaerobic pathogenic bacteria 
still respond to these antibiotics and these antibiot-
ics may act by changing the ecological niche that 
will result in death of the pathogenic anaerobes as 
well. [13]. Adding a drug with anaerobic cover like 
metronidazole has a synergistic effect. [19]. A list of 
drugs useful in dentistry are listed in Table 3. Bacte-
ricidal antibiotics are preferred when the host is im-
mune compromised as bacteriostatic drugs require 
Table 2. Considerations for antimicrobial therapy [13]
Indicated clinical conditions  
for antimicrobial therapy
Non-indicated clinical conditions for antimicrobial 
therapy
1.  Pyrexia within last 24 hours – indicates a systemic 
response to the infection
1. Pain – (Analgesics/ Anti-inflammatory drugs are indicated)
2.  Systemic symptoms like malaise, fatigue, weakness, 
dizziness, rapid respiration and local tender 
lymphadenopathy – indicate an impending sepsis
2. Oedema – (Anti-inflammatory drugs indicated)
3.  Trismus – indicates spread to perimandibular spaces and 
can extend to secondary spaces that can be potentially 
dangerous. Also trismus makes intraoral procedures 
difficult, which must wait until the trismus is relieved.
3. Redness/heat (Anti-inflammatory drugs indicated)
4.  As a prophylaxis in patients with systemic conditions like 
rheumatic heart disease, endocarditis, heart / orthopaedic 
prosthesis.
4. Purulence – (Resolved by drainage of pus / debridement)
5.  In patients with any kind of immunocompromise – AIDS, 
cancer, autoimmune diseases, corticosteroid therapy, 
patients with immune compromised diseases like cyclic 
neutropenia, pancytopenia, uncontrolled diabetes to 
name a few common ones.
5.  Abscess – localized (e.g., alveolar abscesses, periodontal 
abscesses) – (Resolves by incision and drainage)
6.  After solid Organ transplant/grafts (cardiac/renal/bone 
marrow/liver/osseous implants)
6.  Draining sinus tract. (Removal of foci of infection resolves 
drainage and sinus tract may heal on its own or may have 
to be surgically excised.)
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Table 3. Antibiotics useful in Dental Practice
Antibiotic used Cidal/Static Important characteristic
Amoxicillin Cidal
- Better oral tolerance.
- Less chances of toxicity.
- Most odontogenic infections still respond to this drug.
Amoxicillin + clavulanate Cidal
-  Similar to amoxicillin with additional Beta lactamase 
resistance
Cephalosporins Cidal
Useful in selective cases of penicillin allergy and have good 
activity against most oral pathogens but (should not used 
in cases of patients showing Type I hypersensitivity to 
penicillin group of drugs)
Metronidazole Cidal
Active against obligate anaerobes but no activity against 
facultative anaerobes like Streptococci. Useful in stage of 
abscess formation.
Clindamycin Static
Useful in penicillin allergic patients and has a wide 
spectrum of activity including anaerobes. Useful in penicillin 
allergic infections. Risk of superinfection.
Tetracyclines Static
High concentrations achieved in bone and gingival tissues. 
Topical formulations available for use in periodontology
Aminoglycosides Cidal/static
- Injectable drugs
- Active against gram negative odontogenic infections
-  Used in combination with other drugs in severe 
odontogenic infections
- Ototoxicity and hepatotixicity.
Macrolides antibiotics Static
Rapid antimicrobial resistance develops with these newer 
antibiotics and so they must be avoided in dental settings 
when better choices are available.
Fluoroquinolones Cidal
Moxifloxacin has been found to be active against most 
odontogenic micro-organisms. [90]. Useful in minor 
infections in penicillin allergic patients, but better 
alternatives are available and hence not recommended for 
routine use.
the host's immune system to completely eradicate 
the infection [20].
If the decision to prescribe an antibiotic is made, 
it may be necessary to use microbiological testing 
to choose the appropriate antibiotic. Microbiologi-
cal testing by culture and sensitivity tests will help 
choose the best antibiotic. Samples are collected 
in an appropriate manner after consultation with 
the lab and sent immediately, preferably before 
starting any antibiotics. After collection of sample, 
treatment should be started immediately by use of 
empiric antibiotics. For minor infections, amoxicillin 
or amoxicillin/clavulanate is sufficient. A combina-
tion of beta-lactamase resistant penicillin group of 
drug and metronidazole is started in cases of seri-
ous odontogenic infections along with appropriate 
surgical therapy [16,19,21,22]. Routine culture and 
sensitivity are not recommended in minor odonto-
genic infections. These infections respond well to 
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empiric antibiotic therapy with penicillin group of 
drugs. It and so routine culture and sensitivity is not 
cost effective [21]. In case of severe infections or 
infections showing rapid spread, culture and sensi-
tivity might be recommended. One must remember 
that “waiting is wasting” in these scenarios. Empiric 
antibiotic therapy is started and later changed, if 
necessary, based on culture and sensitivity reports.
Appropriate dosage/frequency 
and duration 
Discussing the detailed pharmacology of these 
drugs is beyond the scope of this article but a brief 
discussion of an important pharmacological profile 
of antibiotics may be helpful. 
Antibiotics can have a concentration-dependent 
killing or a time-dependent killing. The concentra-
tion-dependent drugs cause bacterial death when 
present above a particular concentration. Increasing 
the concentration will result in faster killing. Thus a 
single high dose may suffice to achieve the effect. 
e.g, metronidazole. Time-dependent drugs have 
their best effect when present at therapeutic levels 
for a particular period of time. The therapeutic level 
of the drug must be maintained for long periods to 
achieve best effect. Increasing the concentration of 
the drug may have no effect on its efficacy. These 
drugs may be better used by increasing the fre-
quency of administration rather than increasing the 
dose. Penicillin group of drugs belong to this profile 
[13]. This suggests the question of whether 250 mg 
of amoxicillin given 4 times a day is more beneficial 
than 500 mg of amoxicillin given 3 times a day Or is 
250 mg of amoxicillin given thrice a day sufficient? 
And in each of these settings, what is the recom-
mended duration of therapy ? Different prescribing 
trends are present without adequate evidence of 
their efficacy as there are no clear studies on the 
best dosages and frequencies as applicable to den-
tistry.
Higher dose of antibiotic given for a shorter dura-
tion are advocated in recent years [4 ]. This regimen 
would avoid selection of antibiotic resistant species 
and the risk of allergy or adverse events are not 
significantly raised for most dental specific antibiot-
ics. Selection of antibiotic resistant species is com-
mon after using lower dose of antibiotics for longer 
periods of time. But before this, the first question 
to ask oneself is whether an antibiotic is indicated 
in that particular clinical setting in that particular 
patient [3].
A brief tabulation of management of most common 
conditions treated by a dentist with their manage-
ment principles is listed in Table 4.
Antibiotics In Endodontic 
Practice
Most endodontic practice deals with acute and 
chronic pulpal and periapical pathologies. Evidence 
has shown that antibiotics have no effect on the 
pain in case.[10,23,24] Antibiotics are not useful 
in most endodontic infections because it is doubt-
ful that systemic antibiotics are able to achieve an 
adequate therapeutic concentration within the ne-
crotic pulp [25]. Meticulous endodontic technique 
by avoiding over instrumentation will avoid periapi-
cal infections and flare ups during the endodontic 
therapies [26]. Pain during endodontic treatment 
can be avoided by careful instrumentation. Non-
steroidal anti-inflammatory drugs (NSAIDs) can be 
helpful to obtain pain relief [27]. Where endodontic 
treatment is not feasible or in patients with non-
restorable tooth, extraction of the tooth will resolve 
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Table 4. Management of common dental conditions.
Condition Treatment Approach Antibiotics
Uncomplicated endodontic lesion - Debridement of root canal No
Soft tissue swelling of endodontic origin 
(apical abscess / alveolar abscess)
- Debridement of root canal
- Incision and drainage.
No
Endodontic lesion confined to the bone 
(apical periodontitis)
-Trephination of bone to relieve pressure 
and speed healing
No
Periodontal abscess
- Scaling / removal of irritant
- Drainage of pus
No
Chronic periodontitis/ Gingivitis Scaling and root planing No
NUG without systemic complications in 
healthy patients.
- Debridement
- Irrigation
- Scaling and root planing
No
NUG with systemic complications or in 
immune compromised patients / ANUP / HIV 
associated NUG/NUP 
-Debridement
-Irrigation
-Scaling and root planing
-Systemic Antibiotics
Yes. Metronidazole is first choice. 
Penicillin group of drugs may be 
additional adjuvants [35]
Aggressive periodontal diseases / Refractory 
periodontal conditions
- Debridement
- Scaling and root planing
May be considered early in 
generalized aggressive periodontitis 
[91]
Localized abscess
- Incision and Drainage
- Removal of foci of infection
No
Fascial space infections
- Incision and drainage
- Removal of foci of infection
Yes
Complicated endodontic / periodontic 
lesions with signs of systemic spread of 
infection /involvement of fascial spaces
- Removal of foci of infection
- Incision and drainage
Yes
Systemically compromised patients with 
immune defects
Removal of foci of infection by any 
appropriate means
Yes (use of bactericidal drugs 
recommended)
Prior to uncomplicated / complicated 
extractions
 - No
Prior to periodontal surgeries / endodontic 
surgeries
 - No
Prior to Regenerative periodontal therapy 
with membranes / grafting
 - May be *
Prior to implant surgery -
Not necessary in case of single 
implant placement.
*  not supported by strong high quality evidence, NUG Necrotizing Ulcerative Gingivitis, NUP – Necrotizing Ulcerative Periodontitis,  
HIV – Human Immunodeficiency Virus
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the infectious process. As for endodontic surgeries, 
they do not require use of antibiotics in healthy pa-
tients usually, but may be used if deemed necessary 
by the clinician. [3]. Postoperative anti-inflammatory 
drugs will be sufficient to control pain. Postsurgical 
infection is not common after endodontic surgeries 
[28–30].
Acute peri-radicular abscess is a common endodon-
tic infection. A recent review concluded that there 
is insufficient evidence to recommend use of anti-
biotics in cases of apical periodontitis or in acute 
peri-radicular abscesses [11]. In the management of 
acute peri-radicular abscesses, the abscess should 
first be drained by performing a pulpectomy or 
incision and drainage, and relieving any traumatic 
occlusion. If adequate drainage is achieved via inci-
sion and drainage, debridement, and medication of 
the canal system, antibiotics are not required gener-
ally [31,32]. In the event of systemic complications, 
such as fever, lymphadenopathy, or cellulitis or in 
an immunocompromised patient, antibiotics may be 
prescribed in addition to drainage of infection. [32].
Anyibiotics in Periodontal practice 
Periodontitis is a bacterial infection and this has 
been used as a justification for the repeated routine 
use of antibiotics in periodontology. But the clinical 
relevance of bacteria being present in the tissues 
is still not clearly defined in periodontal infections 
and it is inappropriate to make clinical treatment 
such as to use adjunctive systemic antibiotics on 
this premise alone. Montiero et al., [33] conducted 
a survey regarding the use of systemic antibiotics 
by dentists for periodontal diseases and concluded 
that many dentists still use systemic antibiotics in-
correctly, without regard to evidence in published 
literature, for inappropriate indications and using 
inappropriate protocols that are ineffective in peri-
odontal therapy. There is considerable controversy 
on the use of microbial testing in periodontology. 
While some authors suggest that after appropri-
ate and thorough mechanotherapy, microbial test-
ing should be undertaken before starting antibiotic 
therapy [13] the benefit of microbial testing has also 
been questioned [34]. 
Gingivitis and chronic periodontitis
Gingivitis is a local infectious process and responds 
well to local mechanotherapy and antibiotic therapy 
is contraindicated [35]. Routine use of systemic an-
tibiotics in treatment of chronic periodontitis is not 
justified in normal healthy patients. The risks of sys-
temic antibiotics outweigh the benefits for use in 
periodontal diseases [13]. Periodontal pockets can 
be treated by local irrigation of antiseptic / antibiotic 
solutions. The removal of the calculus and infected 
tissue by scaling and root planing procedure with 
irrigation removes the infectious foci and resolves 
the inflammation. The main objective would be to 
disrupt the biofilm mechanically. 
The interrelationship between periodontitis and gly-
cemic control may be considered bidirectional [36]. 
Oral hygiene education and mechanical debride-
ment of plaque and calculus combined with regular 
maintenance is important. When possible, a HbA1c 
of less than 10% should be established before sur-
gical treatment is performed and systemic antibiot-
ics are not needed routinely. Also, periodontal treat-
ment seems to improve glycemic control [37,38], It 
was found that additional use of doxycycline did not 
offer significant benefit in glycemic control [37], but 
when doxycycline was used, the topical local deliv-
ery of doxycycline offered better glycemic control 
(decrease by 10.5%) [39] than systemic doxycycline 
(decrease by 4.7%) [40].
Aggressive periodontal diseases
 
Systemic therapy for treatment of the periodontal 
condition in conjunction with local therapy is indi-
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cated in patients with aggressive periodontitis to 
eliminate the bacteria that invade the gingival tis-
sues and can repopulate the pocket after scaling 
and root planing. The use of antibiotics is beneficial 
only after the biofilm has been disrupted by ap-
propriate mechanotherapy and antibiotics should be 
used only after proper mechanotherapy has been 
used and has been unsuccessful. The use of combi-
nation of amoxicillin and metronidazole in aggres-
sive periodontal diseases is well supported [41–44], 
however well designed controlled clinical trials are 
limited as shown in a recent review [45].
Acute lesions of gingiva/periodontium
 
The two most common acute gingival infections are 
necrotizing ulcerative gingivitis (NUG) and herpetic 
gingivostomatitis. Herpetic gingivostomatitis is a viral 
infection but may be complicated by superinfection 
with bacteria. These diseases occur most often in 
healthy patients, but patients with depressed immu-
nologic responses have an increased risk for these 
gingival entities. Both may appear similar and the 
treatment by debridement is effective for NUG but 
may exacerbate herpetic gingivostomatitis. On the 
other hand, antiviral therapy is effective for herpetic 
gingival lesions but not for NUG. [35].
Necrotizing lesions cause extensive tissue destruc-
tion and necrosis. The treatment is mainly removal 
of the necrotic tissue with pain control. Antibiotics 
are not recommended in NUG patients who do not 
have systemic complications. [35,46]. However, in 
patients with immunologic deficiencies or patients 
with evidence of spread beyond the gingival tissues 
as in necrotizing ulcerative periodontitis (NUP) then 
systemic antibiotics are indicated especially when 
local root planing and curettage is not possible im-
mediately. [35]. Regular daily follow up and debride-
ment with irrigation is required for management of 
this lesion. 
Necrotizing lesions of the gingiva and periodontium 
can progress dramatically in Human Immunodefi-
ciency Virus (HIV) positive patients, thus it is nec-
essary to utilize thorough local therapy combined 
with local use of antimicrobial mouthwashes such 
as chlorhexidine and meticulous oral hygiene by the 
patient. Systemic antibiotics may be used especially 
when systemic complications ensue or anticipated. 
Whenever possible, antibiotics should be avoided 
in significantly immunocompromised individuals to 
minimize the risk of opportunistic infections (i.e., 
candidiasis), superinfection, and micro-organism 
drug resistance [35,46,47].
Periodontal abscess
Periodontal abscesses can often be managed by 
curetting the pocket under local anaesthesia to re-
move plaque or any other aetiologic material. The 
use of systemic antibiotics may be indicated when 
patients have elevated temperatures or show signs 
of cellulitis and have systemic disease/immuno-
Table 5. Signs/symptoms of severe head and neck infections.
Signs/symptoms of systemic spread – pyrexia, malaise and worsening of general condition.
Rapid onset and progress
Infection in immunocompromised patients.
Large swelling involving submental/submandibular or parapharyngeal spaces – potential airway compromise
Presence of trismus indicates involvement of perimandibular spaces and is a serious sign.
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compromised condition. [35,47]. Antibiotic therapy 
alone without subsequent drainage and subgingival 
scaling is contraindicated. [35].
Periodontal surgeries
Systemic antibiotics are generally used after recon-
structive periodontal therapy, although definitive 
information on the advisability of this measure is 
still lacking [48–51].
Simple routine periodontal surgeries do not need 
antibiotics in the postoperative period. Regenera-
tive therapies using bone grafts, allografts and peri-
odontal membranes sometimes require the use of 
antibiotics to prevent infection of the bone graft 
or the foreign material (membranes). Even though 
studies seem to suggest no additional benefit [49–
52], current practice recommends use of antibiotics 
in this scenario. [35]. High dose for a short term, 
would be beneficial not exceeding 5 days, would 
be sufficient in most instances [35]. Consideration 
for peri-implant infections are tabulated in Table 6.
Topical antibiotics in Periodontology
There is a need to reduce the widespread and re-
peated use of topical antibiotics as advocated by 
some manufacturers. Topical antimicrobial therapy 
should be used with same caution as applied to 
systemic therapy. Their indications are similar to sys-
temic antibiotic therapy in periodontology [13].
Table 6. Considerations for peri implant infections.
Condition Criteria for diagnosis Treatment
Peri-implant Mucositis
Inflammation
Bleeding on probing
Peri-implantitis pocket depth < 4 mm
No bone loss
A + B
Peri-implantitis graded according Renvert et al. [92]
Peri-implantitis Grade 0
Failed implant
Implant fracture
Implant mobility > 1 mm horizontal movability
Explant
Peri-implantitis Grade 1 (mild)
BOP
+/- Suppuration
Peri implant pocket depth < 4 mm
Bone loss < 2 mm
Foreign Body in implant sulcus - ? cement
A + B
Peri-implantitis Grade 2
BOP 
+/- Suppuration
PPD 4-6 mm
Bone loss < 2 mm
A + B
Peri-implantitis Grade 3
BOP 
+/- Suppuration
PPD > 6 mm
Bone loss > 2 mm
A + B + C
BOP = bleeding on probing; PPD = Peri implant pocket depth.
A – Mechanical debridement (plastic scalers, rubber cup, air-abrasives), oral hygiene re-education & local antisepsis with chlorhexidine 
0.1–0.2%, irrigation of Peri implant pocket with anti septic agents/antibiotic slurry and application of local antiseptic agent like 
chlorhexidine gel.
B – Removal of abutment.
C – Surgical access & Systemic antibiotic.
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Antibiotics in Oral and 
Maxillofacial Surgery
Antibiotics in minor oral surgery
Most oral surgical procedures in general dental 
practice and in the clinical practice involves simple 
or complicated extraction of teeth, preprosthetic 
hard tissue and soft tissue procedures, periapical 
surgeries, implant placements and soft tissue biopsy 
procedures. These surgical procedures are deemed 
clean contaminated procedures. Clean procedures 
usually do not have risk of postprocedural infec-
tions. Excellent aseptic precautions can reduce the 
infection risk to about 3% to 5% [53]. Antibiotics 
cannot reduce the risk of infection to below 1% 
and may not be warranted. Even though antibiot-
ics are routinely used as surgical prophylaxis and 
in the postprocedural period, there is not enough 
evidence that such usages have a more favourable 
outcome in oral surgery. In general there is overuse 
of antibiotic prophylaxis in minor oral surgery [54–
56,56]. A recent review concludes that about 12 pa-
tients have to be treated with antibiotic to prevent 
one infection and that the risks of antibiotic use 
significantly outweigh the benefits. [57]. The use of 
prophylactic antibiotics prior to implant placement 
is controversial. A systematic review supports the 
use of 2 g amoxicillin as presurgical prophylaxis [58] 
while a few other studies conclude that there is no 
added benefit [59–61]. There is no evidence that 
implant failure is prevented by antibiotic usage [13].
Antibiotics in complex odontogenic 
infections
Odontogenic infections begin with invasion by 
mixed bacterial flora and in the early stages facul-
tative anaerobes such as streptococci predominate 
and cellulitis stage is established. Due to the change 
in the environment inside the infected regions, there 
is a change in the microflora from facultative to ob-
ligate anaerobes and there is formation of abscess. 
Cellulitis is a rapidly spreading progressive infection 
caused by facultative anaerobes whereas abscess is 
predominantly an obligate anaerobic infection with 
well defined margins, fluctuant and is filled with 
pus [13–16,21].
Severe infections of the head and neck should pref-
erably be seen by a specialist early for combined 
antibiotic and surgical management. Severity may 
be indicated by signs/symptoms listed in Table 5.
Penicillin group of drugs remain the drugs of choice 
for early stages of odontogenic infections. After for-
mation of abscess, drugs with anaerobic spectrum 
like metronidazole or clindamycin are indicated. As 
a general rule, if infection has been present for 
more than 2-3 days, it can be expected to have pro-
gressed to obligate anaerobic infection and addition 
of metronidazole along with amoxicillin is beneficial 
[16,19,21]. A short course of high dose antibiotics 
combined with surgical drainage and daily debride-
ment/irrigation as indicated results in quicker resolu-
tion of the infection. In general it's recommended 
that the antibiotic therapy should be continued at 
least 2-3 days beyond resolution of symptoms. [21].
Antibiotic use in maxillofacial trauma
The general consideration is that wound closure 
of clean and clean contaminated wounds like intra 
oral mucosal lacerations or that can be rendered 
clean do not require routine use of antibiotics. Dirty 
wounds or infected wounds would need a debride-
ment before closure or may be treated by delayed 
primary closure or left to heal by secondary inten-
tion. Antibiotics are not a substitute for surgical de-
bridement. Routine use of surgical prophylaxis does 
not seem to offer additional benefit in reduction of 
infections [62–65]. Surgeries performed with due 
care for surgical asepsis do not require prophylactic 
dose of antibiotics beyond the first 24 hours. In-
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fected wounds and fractures/hardware should be 
treated as any maxillofacial infection and the same 
considerations are applicable including surgical re-
moval of the infectious foci with adjunctive use of 
antibiotics.
Concept of surgical prophylaxis in Oral 
and Maxillofacial Surgery
The decision to use prophylactic antibiotics in non-
infected cases should also be based on whether 
patients have any significant medical risk factors 
that could adversely affect their humoral and cellu-
lar immune mechanisms, and whether any systemic 
risks are associated with the bacteremia that ac-
companies tooth extraction. For patients in whom 
postoperative infection may be anticipated the use 
of chemoprophylaxis is recommended. There is no 
evidence that the use of antibiotics beyond 24-48 
hours has any additional benefit. [66]. The classical 
studies on antibiotic prophylaxis recommend that 
the duration of the prophylaxis drug should NOT 
exceed 24 hours. Antibiotics given after that do not 
have a significant benefit and risk of adverse events 
and complications increase beyond that period.
The prophylactic dose of antibiotic is usually double 
the recommended dose [67]. The dose should be 
administered prior to surgery such that the peak 
concentration occurs at the time of taking the in-
cision. Average peak serum levels are reached 60 
-120 minutes after oral administration of amoxicillin 
and immediately after intravenous administration 
of amoxicillin [68,69]. Therefore, oral amoxicillin 1 
gram (double the therapeutic dose of 500 mg) is 
recommended at least 1 hour prior to surgery (as 
the levels peak at about 60–120 minutes after ad-
ministration) are cases done under local anaesthesia. 
Intravenous (IV) antibiotics can be given just prior 
to or a few minutes prior to taking the incision as 
immediately high levels are attained in the blood. IV 
administration is useful in cases done under general 
anaesthesia conveniently administered at the time 
of induction. The concept of antibiotic re-dosing 
may be applicable to complex surgeries of longer 
durations which is rare in usual dental practice. Use 
of multiple drugs have not been found to be benefi-
cial [66]. To In patients who are allergic to penicillin, 
clindamycin may be used [54,70–72].
Pediatric considerations 
Healthy paediatric population require the same con-
sideration as healthy adults. There is often misuse 
of antibiotics in treating children [25]. They are com-
monly over-prescribed and over/underdosed. More 
often, dentists give in to request from the parent 
and fill a prescription for antibiotic even when not 
definitely indicated.
Antibiotic usage in compromised patients 
The rationale behind using antibiotics in medically 
compromised patients with immune defect is that 
they are at a higher risk of infection and infections 
are more difficult to manage in this group of pa-
tients [13,57]. Studies in this population without 
antibiotics is not possible nor ethical. The use of 
antibiotics when used rationally may be beneficial 
in this group of patients. In neutropenic patients 
antibiotic prophylaxis is recommended by some 
especially when absolute neutrophil count (ANC) 
drop below 1000-1500/microlitre [46,73–76], while 
others feel it's not recommended [77]. In general a 
definite guideline/recommendation is lacking in this 
regard. [78]. So, the decision has to be made on a 
case by case basis in consultation with the treat-
ing physician/medical expert. These patients benefit 
with a bactericidal drug as their immune system 
may not be able to clear the infection efficiently 
with bacteriostatic drugs [20].
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Consideration for chemoprophylaxis in 
certain systemic conditions 
Bacteremia occurs whenever there is manipulation 
of gingival tissue, integrity of the mucosal barrier 
is breached and during endodontic instrumenta-
tion. This can be potentially dangerous in patients 
with prosthetic cardiac valves or untreated cardiac 
valve/septal defects and in patients with allograft 
prosthetic joints. The indications for infective en-
docarditis prophylaxis are constantly being revised. 
Regional variations exist in the recommendations 
through the world and the dentist should follow 
the latest regional/national guidelines when pres-
ent. It may be prudent to consult with the treating 
physician before any procedure is planned or refer 
to any card/pamphlet with instruction that the pa-
tient may carry as is customary in certain parts of 
the world. But over the past few years the patients 
for whom infective endocarditis prophylaxis is rec-
ommended has been decreased [79–83]. This is due 
to the lack of definite evidence linking infective en-
docarditis and the dental procedures [84–87]. The 
stress has been placed on cumulative bacteremia 
that occurs due to daily activities like brushing and 
flossing more than the bacteremia that occurs due 
to dental procedures [80,82,84]. Maintaining oral 
health in these at-risk patients can decrease occur-
rence of infective endocarditis [80,82,83].
Recent guidelines for antibiotic prophylaxis in pat-
ents with prosthetic joints has been issued which 
also recommends against the routine practice of 
antibiotic prophylaxis in these patients due to in-
sufficient evidence for linking dental procedures to 
periprosthetic infections [88,89]. The recommenda-
tion is for maintenance of good oral hygiene. A 
detailed discussion of these special topics is beyond 
the scope of this article and the reader is encour-
aged to read through the references cited for a de-
tailed discussion.
Conclusion
To summarise, the definitive indications for antibiot-
ics in dentistry are limited and specific (see Table 
4). Most odontogenic infections can be managed 
by removal of the focus of infection and they re-
spond well to specific limited arsenal of antibiot-
ics like amoxicillin and metronidazole. Appropriate 
antibiotic stewardship and rational prescription of 
antibiotics by dentists is urgently needed in view of 
the pandemic issue of antimicrobial resistance. Edu-
cation in this regard is necessary during the training 
as well as in continuing dental education programs 
to curb antibiotic abuse.
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